Arcline Investment Management, a private equity firm with $1.5 billion of capital under management, is making a strategic investment in Actera Ingredients.
Actera is a leading innovator of functional and sensory cosmetics ingredients, including bio-actives for hair and skin care as well as specialty personal care preservatives derived from nature. The company’s products, tested in clinical studies and in-vivo trials, allow its customers to make important beneficial claims about the efficacy of the ingredients in their proprietary formulations.
Actera CEO Dan Winn said, “This investment enables us to further develop cutting-edge products that the beauty industry is demanding from ingredient suppliers. We like Arcline’s commitment and approach to science-based market driven products.”
Actera is anticipated to be the first of several acquisitions as Arcline builds a bio-actives personal care platform.